tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Okunewitch, 30 are a BUY (90.91%), 3 are a HOLD (9.09%).
Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 26.67% that have a potential upside of 48.13% achieved within 83 days. Previously, Michael Okunewitch worked at BARCLAYS.
Michael Okunewitch’s has documented 59 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BRTX, BioRestorative Therapies at 06-Oct-2026.
Analyst best performing recommendations are on LGVN (LONGEVERON LLC).
The best stock recommendation documented was for LGVN (LONGEVERON LLC) at 3/24/2022. The price target of $1400 was fulfilled within 8 days with a profit of $688 (96.63%) receiving and performance score of 120.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2026
$8
$0.65 (8.84%)
$12
3 months ago
(12-Aug-2026)
0/2 (0%)
$0.77 (10.65%)
Buy Since 18-Oct-2021
$7.5
$0.15 (2.04%)
$25
3 months 23 days ago
(20-Jul-2026)
0/16 (0%)
$0.31 (4.31%)
Buy Since 16-Jan-2026
$16
3 months 26 days ago
(17-Jul-2026)
0/2 (0%)
$12.43 (348.18%)
Buy Since 01-Sep-2021
$7.5
$0.15 (2.04%)
3 months 26 days ago
(17-Jul-2026)
0/3 (0%)
$0.28 (3.88%)
Buy Since 20-Jan-2026
$16
3 months 26 days ago
(17-Jul-2026)
0/4 (0%)
$11.91 (291.20%)
Which stock is Michael Okunewitch most bullish on?
Which stock is Michael Okunewitch most reserved on?
What Year was the first public recommendation made by Michael Okunewitch?
